GGrantIndex
Sort

64,565 grants matching drug discovery

Structure-based strategy for developing inhibitors of the kidney chloride channel CLC-Ka

$580,741
Merritt C Maduke · Stanford University · R01 · FY2025 · DK

Creation of a Marine Natural Products Library to Enhance Life Science Research

$580,729
Amy E Wright · Florida Atlantic University · RC2 · FY2010 · AT

Development of a splicing modulator compound for familial dysautonomia

$580,711
Susan A Slaugenhaupt · Massachusetts General Hospital · UH3 · FY2024 · NS

Use of silver nanostructures on microtransponders in ultra-sensitive assay

$580,711
Wlodek Mandecki · Pharmaseq, Inc. · R44 · FY2011 · CA

Discovery of the next-generation RET-targeted drugs based on nicotinamide scaffold

$580,663
Jie Wu · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · CA

Molecular mechanism for pharmacological activation of KCa2 channels

$580,619
Miao Zhang · Chapman University · R01 · FY2025 · NS

Molecular basis of complement anaphylatoxin receptor activation, regulation, selectivity and signaling bias

$580,563
Cornelius Gati · University Of Southern California · R01 · FY2024 · AI

CVD in American Indians Genetics Center

$580,560
Shelley A Cole · Texas Biomedical Research Institute · R01 · FY2015 · HL

Novel small molecules to treat degenerative lung and blood diseases

$580,560
Suneet Agarwal · Boston Children'S Hospital · R33 · FY2021 · HL

Lineage reprogramming for hearing loss: development of drug screening and gene therapy approaches

$580,483
Neil Segil · University Of Southern California · R01 · FY2017 · DC

Lineage reprogramming for hearing loss: development of drug screening and gene therapy approaches

$580,483
Neil Segil · University Of Southern California · R01 · FY2018 · DC

Synthetic cathinones: a new class of illicit drugs affecting DAT & SERT

$580,458
Louis J De Felice · Virginia Commonwealth University · R01 · FY2014 · DA

The Impact of Human Gene Knockouts in Type 2 Diabetes and Related Traits

$580,453
Michael Boehnke · University Of Michigan At Ann Arbor · R01 · FY2014 · DK

CORE--Drug, Discovery, Design and Synthesis

$580,429
Gunda I. Georg · University Of Kansas Medical Center · U54 · FY2009 · HD

Near-Infrared Fluorescence Nanoparticles for Targeted Optical Imaging

$580,392
Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2009 · CA

Therapy for Metastatic breast cancer based on micro RNA silencing

$580,298
Anna Moore · Michigan State University · R01 · FY2021 · CA

Clinical treatment of advanced Merkel cell carcinoma

$580,211
Isaac Brownell · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2025 · AR

High-Throughput, Highly Multiplexed In Situ Proteomic Imaging of Human Tissues

$579,999
Peng Yin · Harvard University · UH3 · FY2021 · CA

Electrographic Seizure Pattern Modulation Biomarkers in Responsive Neurostimulation for Epilepsy

$579,997
Robert Mark Richardson · Massachusetts General Hospital · R61 · FY2025 · NS

Big Data and Deep Learning for the Interictal-Ictal-Injury Continuum

$579,883
Michael Brandon Westover · Massachusetts General Hospital · R01 · FY2018 · NS

Taking aim at HBV eradication using novel NRTIs and Capsid effectors

$579,866
Stefan G Sarafianos · Emory University · R01 · FY2019 · AI

HIV Infection of Hematopoietic Progenitor Cells

$579,863
Kathleen L Collins · University Of Michigan At Ann Arbor · R01 · FY2015 · AI

Small-molecule STAT3 degraders

$579,830
Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2023 · CA

BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR

$579,810
David G Kingston · Virginia Polytechnic Inst And St Univ · U01 · FY2010 · TW

Pathology Image Informatics Platform for visualization, analysis and management

$579,791
Anant Madabhushi · Case Western Reserve University · U24 · FY2017 · CA